YUYUE MEDICAL(SZ:002223)2024-10-28 00:22Group 1: Market Strategy and Product Development - The company aims to increase market share in respiratory and blood glucose monitoring products over the next 2-3 years by enhancing product quality and offering cost-effective options to compete with international peers [3] - The company focuses on the mid-to-high-end market, leveraging product quality, brand strength, and service capabilities to maintain a leading position in multiple product areas [3] - The CGM (Continuous Glucose Monitoring) products are primarily targeted at the European market, with a strong sales trend and compliance with local standards [4] Group 2: Sales and Marketing Initiatives - The company plans to enhance online sales channels while maintaining a strong focus on product quality and brand development to improve public awareness of healthcare products [4] - The company anticipates stable and orderly investment in marketing based on business development and sales rhythm, particularly during promotional events like Double Eleven [5] - The company is actively pursuing registration for its products in overseas markets, which is expected to drive growth in both domestic and international sales [5] Group 3: Financial Performance and Market Outlook - The electronic blood pressure monitor segment has shown positive growth in the first three quarters of the year, with a significant market penetration rate [6] - The company believes that the aging population and the trend of replacing imports will provide further growth opportunities in the domestic market for blood pressure monitors [6] - The management emphasizes a careful approach to expense planning to ensure a good return on investment while aiming to increase market share and brand power [6]